RE: Angle Plc. FFS! DNA in circulating tumour cells can have DNA that is targetable with modern drugs which is NOT23 Mar 2024 18:34
Thompi
Sure, I appreciate that Parsortix is being used in the research setting for ovarian, lung, prostate, ? also NSCLC, with good results. When I mentioned a one trick pony, it was in reference to the FDA approval. I do not understand why the FDA should limit approval in this way, but such it is. Cynic that I am, I just wonder how easier it might have been for an American firm.
I understand that the hoops that have to be gone through for further approvals are much less onerous than the huge amount required for the initial approval for Ca breast, and I wonder why AGL have not done this. Cost perhaps?. I live in hope for AGL, but optimism thin just now.
Moab